[Severe, life-threatening renal anemia treatment in patients who do not accept heterologous blood transfusion for religious reasons--case report].
The management of severe anemia in patients who do not accept heterologous blood transfusion for religious reasons presents many different challenges both at the level of treatment strategy and ethics. Recently, new interventional treatment strategies have become available, including human and bovine hemoglobin substitutes and high-dose recombinant human erythropoietin. We present the successful management of two Jehovah's Witnesses patients with severe, life-threatening anemia caused by chronic renal failure and exacerbated by sepsis.
Jaroszyński
Andrzej J
AJ
Katedra i Klinika Nefrologii Akademii Medycznej w Lublinie.
Bober-Palak
Ewa
E
Jóźwiak
Lucyna
L
Ksiazek
Andrzej
A
D000328:Adult; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D001803:Blood Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012067:Religion; D012720:Severity of Illness Index; D014183:Transplantation, Heterologous; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin